DOI QR코드

DOI QR Code

Atypical Thymic Carcinoid in a Patient with Zollinger-Ellison Syndrome

  • Lee, Jiyun (Department of Thoracic and Cardiovascular Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Hyun, Kwanyong (Department of Thoracic and Cardiovascular Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Moon, Mi Hyoung (Department of Thoracic and Cardiovascular Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Moon, Seok Whan (Department of Thoracic and Cardiovascular Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Park, Jae Kil (Department of Thoracic and Cardiovascular Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Choi, Si Young (Department of Thoracic and Cardiovascular Surgery, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Sa, Young Jo (Department of Thoracic and Cardiovascular Surgery, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea) ;
  • Kim, Kyung Soo (Department of Thoracic and Cardiovascular Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea)
  • Received : 2019.05.15
  • Accepted : 2019.08.13
  • Published : 2019.12.05

Abstract

Atypical thymic carcinoid is an extremely rare tumor with a poor prognosis. In addition to its known association with multiple endocrine neoplasia type 1, its hallmark characteristics include local invasion and early distant metastasis. In this report, we share our experience treating atypical thymic carcinoid in a patient with Zollinger-Ellison syndrome.

Keywords

References

  1. Ventura L, Gnetti L, Silini EM, et al. Primary atypical carcinoid tumor of the mediastinum: a very rare finding. J Thorac Dis 2017;9:E367-72. https://doi.org/10.21037/jtd.2017.03.154
  2. Zhu S, Wang ZT, Liu WZ, Zong SX, Li BS. Invasive atypical thymic carcinoid: three case reports and literature review. Onco Targets Ther 2016;9:6171-6. https://doi.org/10.2147/OTT.S109693
  3. Jia R, Sulentic P, Xu JM, Grossman AB. Thymic neuroendocrine neoplasms: biological behaviour and therapy. Neuroendocrinology 2017;105:105-14. https://doi.org/10.1159/000472255
  4. Marx A, Chan JK, Coindre JM, et al. The 2015 World Health Organization classification of tumors of the thymus: continuity and changes. J Thorac Oncol 2015;10:1383-95. https://doi.org/10.1097/jto.0000000000000654
  5. Epelboym I, Mazeh H. Zollinger-Ellison syndrome: classical considerations and current controversies. Oncologist 2014;19:44-50. https://doi.org/10.1634/theoncologist.2013-0369
  6. Rea F, Marulli G, Bortolotti L, Feltracco P, Zuin A, Sartori F. Experience with the "da Vinci" robotic system for thymectomy in patients with myasthenia gravis: report of 33 cases. Ann Thorac Surg 2006;81:455-9. https://doi.org/10.1016/j.athoracsur.2005.08.030
  7. Tiffet O, Nicholson AG, Ladas G, Sheppard MN, Goldstraw P. A clinicopathologic study of 12 neuroendocrine tumors arising in the thymus. Chest 2003;124:141-6. https://doi.org/10.1378/chest.124.1.141